Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07217821Not ApplicableRecruiting

Stepped-Care Intervention of Music and Imagery to Assess Relief (SCIMITAR) Trial

Role: collaborator

NCT05222191Phase 2Unknown

Spironolactone in CKD Enabled by Chlorthalidone: PILOT

Role: lead

NCT04223661Phase 2Withdrawn

Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy

Role: collaborator

NCT05426941Not ApplicableUnknown

Feasibility and Acceptability of Music Therapy for Chronic Pain

Role: collaborator

NCT02721446Not ApplicableCompleted

MINDSPACE Strategy for Risk Optimization

Role: lead

All 5 trials loaded